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Abstract
BACKGROUND: Inflammation plays a central role in the pathophysiology of acute coronary syndrome (ACS), 
involving neutrophils as non-specific markers of inflammation and lymphocytes as regulatory markers, measured in 
the form of neutrophil lymphocyte ratio (NLR). C-reactive protein (CRP) plays a role in the blockage of heart arteries 
and serum amyloid A (SAA) plays a role in the pathophysiology of coronary stenosis.
AIM: The study aimed to determine the correlation between NLR, CRP, and SAA levels with the degree of coronary 
artery stenosis in ACS.
METHOD: The design of this study was cross-sectional. The target population in this study was patients with ACS 
in Dr. Kariadi Hospital Semarang. We performed an NLR measurement with a hematologic analyzer, CRP, and SAA 
levels using the ELISA method, and coronary angiography using the Gensini score. Furthermore, we also performed 
the Spearman correlation test between variables.
RESULTS: The median (min; max) values of NLR, CRP, SAA levels, and Gensini score were 4.39 ± 0.48 (0.36; 
18.17); 8.63 ± 2.22 (5; 105.11) mg/dL; 36.859 (3.909–69.724); 65 (6–178), respectively. The correlation between 
NLR, CRP, and SAA levels with the Gensini scores was r = 0.064, p = 0.595; r = 0.240, p = 0.044; r = −0,164, 
p = 0.171, respectively.
CONCLUSION: CRP measurement could be used as a marker of inflammation in ACS to manage the inflammation 
process. Furthermore, SAA levels were clinically useful biomolecular parameters in evaluating acute inflammation in 
ACS, although it did not correlate with the Gensini scores.
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Introduction
Acute coronary syndrome (ACS) is a major 
health problem in both developed and developing 
countries [1], [2]. The prevalence of coronary heart 
disease (CHD) in Indonesia, according to the Basic 
Health Research of Health Research and Development 
Agency in 2013, was 0.5% or 883,447 cases of all non-
communicable disease patients. The prevalence of 
ACS in Central Java was 0.5% or 120,447 cases [3]. 
Based on the American Heart Association (AHA) data, 
men and women (aged >50 years) have the same 
prevalence of CHD as they age [4], [5].
ACS is a cardiac emergency with clinical 
manifestations of chest pain or other symptoms as a 
result of myocardial ischemia. Clinical manifestations of 
ACS could be unstable angina pectoris, non-ST-elevation 
myocardial infarction (NSTEMI), and ST-elevation 
myocardial infarction (STEMI) [6]. According to the 
AHA, the American College of Cardiology, and the 
European Society of Cardiology, the diagnosis of ACS 
can be established based on history taking, 12-Lead 
ECG examination, and increased cardiac markers. The 
diagnosis of ACS made when two out of three criteria 
met [4], [6], [7].
Inflammation plays a central role in the 
pathophysiology of ACS. ACS is often associated 
with atherosclerotic plaque rupture and total or 
partial occlusions of arterial infarction [8]. Increased 
inflammatory markers, especially C-reactive protein 
(CRP), are associated with an increased risk of 
cardiovascular events. Previous studies showed that 
CRP was not only a marker of inflammation but also 
having an active role in atherogenesis [9]. Haidari et al. 
investigated the correlation between CRP serum levels 
and CHD by angiography of 450 individuals. CRP levels 
in patients with CHD were significantly higher than the 
patients in the control group (2.14 mg/L vs. 1.45 mg/L), 
and this correlation indicated an inflammatory process 
in CHD [10], [11].
Neutrophil lymphocyte ratio (NLR) is a 
combination of inflammatory markers, consisting of 
neutrophils as non-specific markers of inflammation and 
 Limijadi et al. Correlation Between NLR, CRP, and SAA with Stenosis Degree in ACS
Open Access Maced J Med Sci. 2020 Dec 11; 8(B):1234-1239. 1235
lymphocytes as regulatory markers. NLR has a better 
predictive value compared to total leukocyte count or 
neutrophil type count as a marker of cardiovascular 
disease and has been introduced as a potential 
marker for detecting inflammatory processes in cardiac 
abnormalities and as a predictor of long-term mortality 
in ACS patients [12].
Serum amyloid A (SAA) consists of an acute 
phase reactant protein produced by the liver as an acute 
and chronic inflammatory response. The production of 
SAA is due to the response to cytokines of IL-6 whose 
levels can increase 1000 folds [13], [14]. SAA played 
a role in the pathophysiology of atherosclerosis and 
coronary stenosis. Some studies also found SAA as 
apolipoprotein in HDL particles and played a role in 
the acute modification of cholesterol transport during 
physiological stress. SAA also showed the chemotactic 
effects on monocytes. Previous studies showed that 
there were significant differences in SAA levels between 
subjects with coronary stenosis and without coronary 
stenosis [13], [14], [15].
The process from atherosclerosis to the 
occurrence of ACS is chronic inflammation. Therefore, 
we used the laboratory parameters of NLR, CRP, and 
SAA in the study as inflammatory markers of ACS. 
These parameters were related to the occurrence of 
atherosclerosis. NLR can be an important measure 
of inflammation in ACS due to its cost-effectiveness, 
availability, and easy calculation. Furthermore, NLR, 
CRP, and SAA measurements are non-invasive 
laboratory tests expected to detect the early occurrence 
of chronic processes in stable CHD. Determination of the 
degree of stenosis used in this study was quantitatively 
obtained from the results of coronary angiography or 
cardiac catheterization and calculated using the Gensini 
score. The score was easy to calculate and more 
applicable. Based on these theories, the study aimed 
to determine the correlation between NLR, CRP, and 
SAA levels with the degree of coronary artery stenosis 
in ACS.
Methods
This study was an analytical observational 
study with a cross-sectional design conducted at Dr. 
Kariadi Hospital Semarang from April to September 
2019. The subjects of the study were 32 patients 
diagnosed with ACS by Cardiologists and underwent 
coronary angiography. There were many refusals of 
the ACS patient to join this research so that the sample 
number was small. We performed consecutive sampling 
on subjects who met the inclusion and exclusion 
criteria of the study. The inclusion criteria were man, 
normal body temperature, and underwent coronary 
artery angiography. The exclusion criteria were a 
history of cancer, underwent chemo/radiotherapy, 
past infection, history of ACS, history of liver disease, 
coagulation impairment, hypercholesterolemia, and 
autoimmune. We collected the data from history taking, 
physical examination, ECG examination, angiography 
examination, and laboratory examination. We also 
measured urea and creatinine levels to ensure the 
study subjects did not experience impaired kidney 
function that could affect SAA levels.
NLR was the result of a comparison between 
absolute neutrophil count and absolute lymphocyte 
count. The measurements of absolute neutrophil count 
and absolute lymphocyte count were performed using 
a Sysmex XN-1000 hematology analyzer (Sysmex, 
Japan). We measured the CRP serum levels using 
the hsCRP ELISA method, expressed in mg/L units. 
The measurement of the CRP serum levels was 
performed using an i-Chroma device with a reference 
value of <5 mg/L (Boditech Med Inc., South Korea). 
Furthermore, we measured the SAA serum levels using 
the ELISA method (AssayMaxTM Human SAA ELISA 
Kit, Assay Pro). The SAA serum levels were expressed 
in µg/mL units with the reference values of ≤6 µg/mL. 
The degree of coronary artery stenosis obtained from 
coronary angiography was expressed based on the 
Gensini score, which is interpreted by two Cardiologists 
after conducting an agreement test.
We processed the data using SPSS and 
conducted a normality test. The correlation between 
variables was analyzed using the Spearman test. 
Statistical test results were significant if the p < 0.05. 
This study obtained ethical approval from the Ethics 
Commission of the Faculty of Medicine of the Diponegoro 
University. All of the participants gave written consent to 
participate in this study.
Results
During the study, we found 32 subjects, 
consisting of 27 (84.4%) men and 5 (15.6%) women. A 
total of 12 (37.5%) subjects had a diagnosis of NSTEMI 
and 20 (62.5%) subjects had a diagnosis of STEMI. 
The mean age of the study subjects was 58.8 ± 11.12 
years with a range of 32-73 years. Table 1 shows the 
characteristics of the study subjects.
We classified the severity of coronary 
lesions into mild, moderate, and severe based on the 
modified Gensini score. There were 5 (16%) subjects 
with mild coronary lesions, 10 (31%) subjects with 
moderate coronary lesions, and 17 (53%) subjects with 
severe coronary lesions, as presented in Table 2.
Most of the study subjects were STEMI 
patients (62.5%) with risk factors of smoking, 
hypertension, diabetes mellitus, and dyslipidemia. 
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Among the subjects of the study, 15 (46.87%) were 
smokers, 18 (56.25%) had dyslipidemia, 19 (59.37%) 
had hypertension, 6 (18.75%) had hyperglycemia, and 
12 (37.5%) had a history of diabetes mellitus. Table 3 
shows the distribution of risk factors in the subjects of 
the study.
Table 2: The degree of coronary artery stenosis
Degree of coronary artery stenosis Number Percentage
Mild 5 16
Moderate 10 31
Severe 17 53
We performed a bivariate correlation test 
between NLR, CRP, and SAA parameters with the 
degree of stenosis using the Spearman correlation test. 
Table 4 shows the results of the correlation test.
Table 3: The risk factors of ACS
Risk factors Number (patients) Percentage
Dyslipidemia
Yes 18 56.25
No 14 43.75
Hyperglycemia
Yes 6 18.75
No 26 81.25
Hypertension
Yes 19 59.37
No 13 40.63
Smoking
Yes 15 46.87
No 17 53.13
Diabetes mellitus
Yes 12 37.5
No 20 62.5
ACS: Acute coronary syndrome.
The result of the Spearman correlation test 
showed no correlation between NLR and the degree of 
stenosis (r = 0.064; p = 0.595). In the other hand, the 
Spearman correlation test between CRP levels and the 
degree of stenosis showed a weak positive correlation 
(r = 0.240; p = 0.044). The correlation test between SAA 
levels with the degree of stenosis using the Spearman 
correlation test showed r = −0.164 with a p = 0.171, 
meaning that there was no correlation between them.
Table 4: The correlation between NLR, CRP, and SAA levels 
with the Gensini score
Parameters Gensini score
r p
NLR 0.064 0.595
CRP levels 0.240 0.044
SAA levels −0.164 0.171
The correlation was significant if p<0.05. NLR: Neutrophil lymphocyte ratio, CRP: C-reactive protein, 
SAA: Serum Amyloid A.
Discussion
The mean age of the study subjects was 58.8 
± 11.12 years, with the youngest age was 32 years, 
and the oldest was 73 years. This result was consistent 
with the results of the 2013 Basic Health Research, in 
which the prevalence of ACS increased with age [3]. 
Increased age is associated with structural changes in 
the coronary arteries, in which the arterial walls become 
stiffer. Furthermore, the changes in molecular biology 
in elderly patients also cause arterial endothelial 
dysfunction. The study subjects consisted of 27 
(84.4%) men and 5 (15.6%) women, which indicated 
that the incidence of ACS was more common in men 
than in women. This result was consistent with the 
study of Montalescot et al. (2013), in which 83.7% of 
the ACS cases found in men [16]. Men tend to have 
a greater risk of CHD than women in adulthood. The 
incidence of ACS in premenopausal women was lower 
than those in men and postmenopausal women due 
to their hormonal factors. Premenopausal women had 
endogenous estrogen, which provided a protective 
effect against CHD [17]. Some study subjects had risk 
factors of ACS, namely smoking, diabetes mellitus, 
hypertension, hyperglycemia, and dyslipidemia. The 
result of the study found that 19 (59.37%) of the subjects 
had hypertension. The mean systolic pressure of the 
subjects was 136.37 ± 25.25 mmHg with a median of 
137 (90–178) mmHg, while the mean diastolic pressure 
was 84.53 ± 15.09 mmHg with a median of 82.5 (59–
110) mmHg. Chronic high blood pressure can damage 
blood vessel walls and make it more susceptible to 
narrowing and plaque deposition, which is associated 
with atherosclerosis [8].
CHD is a macrovascular complication of 
diabetes mellitus. Atherosclerotic lesions in diabetes 
mellitus occur due to hyperglycemia, which causes 
endothelial dysfunction. The hyperglycemia state 
will increase the tendency for oxidative stress 
and an increase in oxidized LDL, which is more 
atherogenic [18], [19]. The mean fasting blood glucose 
level of the study subjects was 153.17 mg/dl, with a 
median of 160 (87–420) mg/dl. In this study, 12 (37.5%) 
subjects had type 2 diabetes mellitus.
The role of dyslipidemia is essential in the 
process of atherosclerosis, which triggers the occurrence 
of ACS. Dyslipidemia, defined as abnormalities in lipid 
metabolism, is characterized by an increase or decrease 
in plasma lipid fractions. Lipid fraction abnormalities 
include an increase in total cholesterol, LDL cholesterol, 
and triglycerides levels and decreased HDL levels [20]. 
The measurement of lipid profiles in the study showed 
that 18 (51.6%) subjects had dyslipidemia. Grundy 
et al. (2009) showed strong evidence of a correlation 
between LDL cholesterol and cardiovascular events.
The study included 15 (46.87%) subjects 
with a history of active smoking, all of whom were 
Table 1: The characteristics of the subjects of the study
Parameter Mean±SE Median (Min–Max)
Age (years) 60±1.20
Total cholesterol (mg/dl) 185 (150–250)
Triglycerides (mg/dl) 142 (100–255)
LDL (mg/dl) 120±3.95
HDL (mg/dl) 37 (30–57)
Systole (mmHg) 137 (90–178)
Diastole (mmHg) 82.5 (59–110)
Urea (mg/dl) 32 (13–96)
Creatinine (mg/dl) 1.1±0.24
Random blood glucose (mg/dl) 160 (87–420)
ANC 9.37±0.43
ALC 1.82 (0.54–12.01)
NLR 4.39 (0.36–18.17)
CRP levels (mg/dl) 8.63 (5–105.11)
SAA levels 36.859 (3.909–69.724)
Gensini score 65 (6–178)
Troponin 18.29 (0.045–50)
Comments: SE, Standard error; min: minimal value; max: maximal value. NLR: Neutrophil lymphocyte ratio, 
CRP: C-reactive protein, SAA; Serum Amyloid A.
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men. Smoking is a strong risk factor of ACS due to 
its ability to accelerate the process of atherosclerosis 
through several mechanisms. Exposure to cigarette 
smoke molecules causes blood vessel walls to release 
inflammatory mediators and cytokines, which indirectly 
cause damage to blood vessel walls. The study did not 
base the subjects on one risk factor only. Some subjects 
had more than one risk factor of ACS that was different 
from each other and caused the diverse conditions of 
the subjects.
We used Troponin I examination as a diagnostic 
criterion in study subjects with a mean value of 20.20 ± 
19.26 µg/L. The results of NLR examination of the study 
subjects showed an average of 6.10 ± 3.98. Coronary 
angiography examination aimed to demonstrate the 
coronary anatomy and the degree of lumen obstruction 
of the coronary arteries. The results could identify 
coronary lesions starting from the location, length, 
diameter, and shape of the arteries, the degree of 
coronary lumen obstruction, the characteristics of the 
obstruction including atheroma, thrombus, dissection, 
spasm or bridging, and assessing the blood flow. 
Moreover, it could assess the presence of coronary 
artery collaterals. The Gensini scores divided the degree 
of stenosis into mild (Gensini score of 1–30), moderate 
(Gensini score of 30–60), and severe (Gensini score of 
>60). The mean Gensini score in this study was 70.53 
± 38.49.
The correlation test between NLR and the 
degree of coronary stenosis in this study showed no 
correlation (r = 0.064; p = 0.595). This result could be 
explained because the modified Gensini score was 
the percutaneous coronary intervention system. The 
modified Gensini score is the most comprehensive 
coronary artery bypass grafting score in assessing the 
severity of coronary lesions because it includes the 
number of stenotic arterial segments, the degree of 
arterial lumen stenosis, and the location of the stenotic 
segment. It includes eight coronary artery segments 
grouped by its severity of occlusion (score 1 for stenosis 
of <50%, score 2 for stenosis of 50–74%, score 3 for 
stenosis of 75–99%, and score 4 for total occlusion). 
Each blood vessel segment, whose degree of stenosis 
has been measured, is added up, then multiplied by the 
value determined according to the area of the coronary 
arteries involved (the left main coronary artery × 5; the 
proximal left anterior descending [LAD] coronary artery 
× 2.5; the proximal circumflex artery × 2.5; mid LAD 
× 1.5; right coronary artery, distal LAD, posterolateral 
artery, and obtuse marginal artery × 1; other segments 
× 0.5). The Gensini score assessment divided the 
degree of stenosis into mild (score of 1–6), moderate 
(score of 7–13), and severe (score of >13) [21].
Li et al. (2018) showed that the NLR level 
was significantly higher in the chronic occlusion group 
compared to those in the acute coronary stenosis 
group, as in ACS [22]. Furthermore, the inflammatory 
process in the course of the disease occurred in all 
coronary arteries from the main artery, the arterial 
branches to the distal arteries. Both inflammations 
that occurred locally in the coronary arteries and that 
occurred systemically played roles in the destabilization 
and rupture of atherosclerotic plaque that could cause 
acute cardiovascular events [8]. The criteria based on 
the number of damaged blood vessels or the degree of 
stenosis of the blood vessels could not systematically 
reflect the severity of the disease. These reasons 
caused no correlation between NLR and the degree of 
stenosis in this study.
The correlation test between CRP levels and 
the degree of coronary stenosis in this study showed 
a weak positive relationship (r = 0.240; p = 0.044). 
This value indicated that an increase in CRP levels 
was directly proportional to the severity of coronary 
stenosis. CRP is one of the substances found in 
atherosclerotic lesions in the tunica intima along with 
monocytes, monocyte-derived macrophages, and 
lipoproteins, which shows that CRP is directly related 
to the process of atherosclerosis [23], [24]. The study 
conducted by Habib and Masri in 2013 on 87 CHD 
patients showed that there was a positive correlation 
between CRP and the severity of stenosis (r = 0.423; 
p = 0.018) [25]. In the other hand, the study conducted 
by Mansoor et al. (2014) reported that patients with 
high CRP levels were at risk for severe coronary 
lesions during early adulthood. The study also used the 
Gensini score (p < 0.01, r = 0.6692) [26].
The correlation test between SAA levels and 
the degree of coronary stenosis in this study showed no 
correlation (r = −0.164; p = 0.171). SAA, in theory, plays 
a role in the pathophysiology of coronary stenosis. 
SAA is an acute-phase protein produced by the liver in 
response to inflammation, whose levels can increase 
1000 folds. This study found extremely high SAA 
levels. However, it was not correlated to the degree of 
coronary stenosis, although the percentage of patients 
with moderate and severe stenosis was 84%. Despite 
the absence of a correlation between high SAA levels 
and the degree of stenosis, the finding of high SAA 
levels in ACS needs special attention. SAA can be 
found as apolipoprotein in HDL molecules and shows 
chemotactic effects on monocytes and T lymphocytes. 
SAA molecules allow vascular damage and induce 
matrix metalloproteinase expression, which causes 
atherosclerosis [27], [28].
SAA removes Apo A-1 from HDL to form larger 
and denser HDL molecules, thereby reducing the ability 
to catalyze cholesterol esterification. SAA-HDL bond is 
not able to prevent LDL oxidation and even strengthens 
the formation of foam cells, which then becomes a fatty 
streak at the beginning of the development of coronary 
stenosis. SAA molecules can be distributed not only in 
HDL but also in LDL particles. The oxidative interactions 
between SAA and LDL form the binding of SAA to LDL, 
which is catalyzed by ROS. The early appearance of 
stable plaque with a small extracellular lipid content 
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and cholesterol ester and thick fibrous capsule leads 
to stable coronary with increased SAA levels [27], [28].
This study did not investigate each type 
of ACS, which might provide different information 
compared to the overall analysis. It needed a larger size 
of the sample in the analysis of each type of ACS. This 
study did not analyze the comorbid factor presented 
in the subjects, so further study is required. Finally, 
further study was needed to investigate the correlation 
between inflammatory parameters and other cardiac 
stenosis scoring systems.
Conclusion
CRP examination could be beneficial as a 
marker of acute inflammation in the condition of ACS to 
manage the inflammation process.
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